Q9981 — Rolapitant, oral, 1 mg
Q9981 is a HCPCS Level II code for rolapitant, oral, 1 mg. It belongs to the Temporary Codes section. It was terminated on December 31, 2016 and is not valid on new claims.
This code has been terminated
CMS terminated Q9981 on December 31, 2016. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for Q9981
- Long descriptor
- Rolapitant, oral, 1 mg
- Short descriptor
- Rolapitant, oral, 1mg
- Added
- July 1, 2016
- Terminated
- December 31, 2016
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to Q9981
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If Q9981 is not quite right, the correct code is very often within a few positions of it.
- Q9973Injection, epoetin beta, 1 microgram, (non-esrd use)terminated
- Q9974Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgterminated
- Q9975Injection, factor viii fc fusion protein (recombinant), per iuterminated
- Q9976Injection, ferric pyrophosphate citrate solution, 0.1 mg of ironterminated
- Q9977Compounded drug, not otherwise classifiedterminated
- Q9978Netupitant 300 mg and palonosetron 0.5 mgterminated
- Q9979Injection, alemtuzumab, 1 mgterminated
- Q9980Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mgterminated
- Q9982Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Q9983Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Q9984Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mgterminated
- Q9985Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgterminated
- Q9986Injection, hydroxyprogesterone caproate, (makena), 10 mgterminated
- Q9987Pathogen(s) test for plateletsterminated
- Q9988Platelets, pheresis, pathogen-reduced, each unitterminated
- Q9989Ustekinumab, for intravenous injection, 1 mgterminated
Questions about Q9981
What is HCPCS code Q9981?
Q9981 is a HCPCS Level II code for rolapitant, oral, 1 mg. It sits in the Temporary Codes section.
Does Medicare cover Q9981?
The CMS HCPCS file marks Q9981 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is Q9981 still valid?
No. Q9981 was terminated on December 31, 2016 and should not be used on new claims.